Education
About Us
Working with TipRanks
Follow Us
TherapeuticsMD (TXMD)
NASDAQ:TXMD
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.30M | $ 69.96M | $ 86.95M | $ 64.87M | $ 49.65M |
| Gross Profit | $ 1.30M | $ 68.57M | $ 68.11M | $ 48.90M | $ 43.31M |
| Operating Income | $ -8.52M | $ 20.14M | $ -139.77M | $ -155.54M | $ -151.21M |
| EBITDA | $ -8.40M | $ 11.86M | $ -78.57M | $ -149.47M | $ -156.31M |
| Net Income | $ -10.28M | $ 112.00M | $ -205.60M | $ -212.70M | $ -196.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.33M | $ 38.07M | $ 65.12M | $ 80.49M | $ 160.83M |
| Total Assets | $ 43.31M | $ 90.46M | $ 169.47M | $ 181.61M | $ 265.99M |
| Total Debt | $ 8.01M | $ 8.76M | $ 196.33M | $ 246.37M | $ 203.78M |
| Net Debt | $ 3.68M | $ -29.31M | $ 131.21M | $ 165.89M | $ 42.95M |
| Total Liabilities | $ 14.02M | $ 55.31M | $ 263.09M | $ 305.61M | $ 256.78M |
| Stockholders' Equity | $ 29.29M | $ 35.14M | $ -93.62M | $ -124.00M | $ 9.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -48.14M | $ -4.43M | $ -144.92M | $ -161.07M | $ -189.59M |
| Operating Cash Flow | $ -48.14M | $ -4.08M | $ -142.69M | $ -159.47M | $ -165.70M |
| Investing Cash Flow | $ 0.00 | $ 223.48M | $ -2.22M | $ -1.60M | $ -23.91M |
| Financing Cash Flow | $ 3.15M | $ -235.21M | $ 129.55M | $ 80.72M | $ 188.83M |